Others

Google launches an AI-powered image generator

February 1, 2024

Taylor Swift deepfakes be damned, Google is releasing a new AI-powered tool, TextFX, for image creation. Underpinned by Imagen 2, a GenAI image model developed by Google’s DeepMind team, TextFX offers a prompt-based UI to create and edit images. That’s no different than tools like OpenAI’s DALL-E 3, Midjourney, Meta’s Imagine with Meta AI and […]

© 2024 TechCrunch. All rights reserved. For personal use only.

Okta lays off 400 employees — almost exactly a year after last staff cuts

February 1, 2024

U.S. access and identity management giant Okta has said it is laying off approximately 400 employees, or 7% of its global workforce. The layoffs come almost exactly a year to the day after Okta announced plans to reduce its workforce by 5%, about 300 employees. In an email sent to employees, which Okta shared with […]

© 2024 TechCrunch. All rights reserved. For personal use only.

AI2 open sources text-generating AI models — and the data used to train them

February 1, 2024

The Allen Institute for AI (AI2), the nonprofit AI research institute founded by late Microsoft co-founder Paul Allen, is releasing several GenAI language models it claims are more “open” than others — and, importantly, licensed in such a way that developers can use them unfettered for training, experimentation and even commercialization Called OLMo, an acronym […]

© 2024 TechCrunch. All rights reserved. For personal use only.

Cast your votes for TC Early Stage Audience Choice Roundtables

February 1, 2024

A not-so-humble brag here, so brace yourself. The programming at TechCrunch Early Stage — April 25 in Boston, Massachusetts — is gonna be off the proverbial hook. How do we know? We read hundreds of applications from experienced founders and startup ecosystem experts eager to participate in Audience Choice for a chance to present at […]

© 2024 TechCrunch. All rights reserved. For personal use only.

3 Smart Pharma Picks Serving Gains

February 1, 2024
With rising healthcare expenditure, growing need for precision medicine, innovations in biologics and gene editing, and rapid adoption of advanced technologies, the pharma industry is well-poised for significant growth and…